- Ut imperdiet leo id lorem fermentum consectetur.
- Ut vitae orci et dui varius tincidunt.
- Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Marketing & Strategy
Customer-Centric Engagement During COVID-19

Navigating the multichannel maze in COVID 19 times to engage healthcare professionals (HCPs) and patients has been challenging for most local marketing, medical and commercial teams.
In the last few weeks, Health Industry Hub gained insights from several clinicians (GPs, specialists and surgeons) on how the COVID-19 pandemic has impacted their day-to-day world in clinics and with their patients. See infographic below.
In overwhelming times, most HCPs are not looking to engage with the field force in one-on-one virtual meetings or phone calls unless there is a compelling reason to do so, for example, clinical trials, virtual advisory boards, new registration / reimbursement of medicines or medical devices.
Instead, HCPs are interested in receiving valuable, cross-functional medical content that is easy to access and is of benefit to them and/or their patients.
Click on the image below to learn more.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.
News & Trends - Medical Technology

Technology levels up support for healthcare employees – Matt Moran, MD, Philips
MedTech News: Matt Moran, Managing Director of Philips Australia & New Zealad, reflects on the impact of the COVID-19 pandemic […]
MoreMedical

Aussie researchers receive $2.9m funding boost for multiple sclerosis
Medical News: Twenty multiple sclerosis (MS) scientific research teams across the country will receive an important New Year funding injection […]
MoreNews & Trends - Biotechnology

AusBiotech renews agreements with international stakeholders
Biotech News: AusBiotech’s international partnerships have been extended, with new Memorandums of Understanding (MoU) signed with major international industry associations […]
MoreNews & Trends - Pharmaceuticals

AbbVie’s phase 3 wins for Humira successor Skyrizi
Pharma News: AbbVie is in a race against time as patent expiry of its Humira inflammatory diseases blockbuster draws near […]
More